XPhyto Therapeutics
-
XPhyto Therapeutics Launches Rapid Test for COVID-19, Zacks Research Initiates Coverage
XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF | FSE: 4XT) (“XPhyto”) is a bioscience company with a…
-
Patient Heal Thyself.
Many, many years ago I worked in the crude oil marketing business with a gentleman (and I use…
-
Hugh Rogers on the European approval of the XPhyto Therapeutics point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE:…
-
XPhyto Therapeutics is looking to hit a home run with their innovative medical products and therapies
New therapies and diagnostics in the pharmaceutical and medical industries can be a very lucrative area. To be…
-
XPhyto Therapeutics Hugh Rogers on the fastest and most portable PCR test available
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.…
-
XPhyto Therapeutics moving forward from successful prototype testing of saliva virus test
Non-invasive test can detect viral RNA in asymptomatic patients XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF |…
